Does the teicoplanin skin test predict IgE-mediated hypersensitivity? [PDF]
Baştuğ İnan NB +3 more
europepmc +1 more source
Pharmacokinetics of teicoplanin
We investigated the pharmacokinetic properties of teicoplanin, after 200 mg i.v. and i.m. administration in 10 healthy male subjects by assuming a three-compartment open model with elimination from the central compartment.
L. Ferrante +3 more
core
The Effectiveness of Linezolid and Teicoplanin for Managing Infections After Burn Injuries: A Retrospective Study. [PDF]
Zendehdel A +4 more
europepmc +1 more source
<i>Serratia marcescens</i> peritonitis in a continuous ambulatory peritoneal dialysis patient: A case report and literature review. [PDF]
Altınyüzük O +5 more
europepmc +1 more source
The Comparison of Serum Teicoplanin Trough Concentrations Under Two Different Loading Doses
研究背景:作為第一線治療多重抗藥性菌種所造成感染的重要抗生素之一,teicoplanin的療效取決於藥品濃度超過致病菌之最低抑制濃度(minimum inhibitory concentration,MIC)的時間長短,有鑑於臺灣近年格蘭氏陽性菌的抗藥性日益嚴重,臨床MRSA (methicillin-resistant Staphylococcus aureus)分離菌株對於teicoplanin的MIC逐漸增加至2 mg/L,藥品血中濃度建議至少維持在10 mg/L,甚至20 mg/L以上。然而 ...
Liao, Hsin-i, 廖欣誼
core
Methicillin-Resistant Staphylococcus aureus Bacteremia Originating From a Ureteral Stent-Associated Urinary Tract Infection: A Case Report. [PDF]
Kawaguchi Y, Kurogi J.
europepmc +1 more source
Early Diagnosis and Successful Treatment of Influenza Coinfection With Community-Onset Methicillin-Resistant <i>Staphylococcus aureus</i> Necrotizing Pneumonia: A Case Report. [PDF]
Chan PK, Wu CH.
europepmc +1 more source
Breakthrough <i>Pediococcus acidilactici</i> and <i>Leuconostoc lactis</i> bacteraemia with elevated meropenem minimum inhibitory concentrations during broad-spectrum antimicrobial therapy in a patient with advanced pancreatic cancer: A case report and review of the literature. [PDF]
Du A +9 more
europepmc +1 more source
Cost-effectiveness analysis of linezolid versus vancomycin in the treatment of adult hospital-acquired and ventilator-associated methicillin-resistant staphylococcus Aureus Pneumonia (a systematic review). [PDF]
Moghadam EM, Jahangiri R, Hadian M.
europepmc +1 more source
Development of a real-world, therapeutic drug monitoring-informed model to predict teicoplanin daily dose in pediatric intensive care unit patients with bacterial infections. [PDF]
Wang F +10 more
europepmc +1 more source

